you are here:
Success
Alert
Please select a Day.
Info
1,474.70
21.70 (1.49%)

As on 25 Feb, 2021 | 03:53

Trade
Day Range
1450.10
1482.50
L H
52 Week Range
962.65
1807.50
L H
Volume
65,907
1,479.00
23.70 (1.63%)

As on 25 Feb, 2021 | 04:00

Day Range
1451.25
1481.00
L H
52 Week Range
1046.40
1805.00
L H
Volume
6,428
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open1,467.40
          Previous Close1,453.00
          UC Limit1,743.60
          LC Limit1,162.40
          Volume65,907.00
          VWAP1,467.92
          Mkt Cap (Rs. Cr.)24,982
          20D Avg Volume62,953
          20D Avg Delivery38,878
          Beta0.420.37
          Face Value10.00
          TTM EPS28.45
          TTM PE51.83
          Sector PE38.35
          Book Value Per Share107.47
          P/B13.73
          Dividend Yield2.71
          P/C44.25

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators

          Price
          • Mid Range Momentum - Stock is Mid Range compared to Short, Medium and Long Term Moving Averages
          • 53.22% away from 52 week low
          • 18.4% away from 52 week high
          • Underperformer - GlaxoSmithKline Pharmaceuticals down by -0.89% v/s NIFTY 50 up by 6.03% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          8

          indicates Strong Financials

          3 year CAGR growth
          Revenue 3.5%
          NetProfit -34.8%
          OperatingProfit 16.2%
          Industry Comparison
          • TTM PE Ratio - High in industry
          • Market Cap - High in industry
          • Price to Book Ratio - High in industry
          • TTM PEG Ratio - Below industry Median
          Shareholding Pattern
          • Promoters holding remains unchanged at 75.0% in Dec 2020 qtr
          • Mutual Funds have decreased holdings from 4.53% to 3.99% in Dec 2020 qtr
          • Number of MF schemes decreased from 22 to 21 in Dec 2020 qtr
          • FII/FPI have increased holdings from 0.98% to 1.54% in Dec 2020 qtr.
          • Number of FII/FPI investors decreased from 133 to 128 in Dec 2020 qtr
          • Institutional Investors have increased holdings from 12.24% to 12.31% in Dec 2020 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying GlaxoSmithKline

          What's your call on GlaxoSmithKline today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          23 Feb, 2016

          NEW INDIA INVESTMENT TRUST PLC

          Qty 69000 Price 3219.1 % Traded 0.04
          23 Feb, 2016

          NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED

          Qty 69000 Price 3219.1 % Traded 0.04

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          Insider Transaction Summary

          Mar, 30, 2017

          Castleton Investment Ltd

          Promoter
          Qty 3192238 Price 2725 % Traded 1.88 Post Tnx Hold. 0%
          Mar, 30, 2017

          GlaxoSmith Kline Pet Ltd

          Promoter
          Qty 3192238 Price 2725 % Traded 1.88 Post Tnx Hold. 28.1%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          Dec, 20, 2019

          Life Insurance Corporation of India

          Other
          Qty 3402936 Price 0 % Traded 2.00 Post Tnx Hold. 5.99%
          Mar, 30, 2017

          GlaxoSmithKline Pte Ltd

          Other
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%
          Mar, 30, 2017

          GlaxoSmithKline Pte Ltd & Others

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 28.1%
          Mar, 30, 2017

          GlaxoSmithKline Pte Ltd and PACs

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%
          Mar, 21, 2017

          GlaxoSmithKline Pte Ltd (Revised)

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%
          Mar, 24, 2014

          Aberdeen Asset Management Asia Ltd

          Other
          Qty 12636245 Price 0 % Traded 14.91 Post Tnx Hold. 1.54%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          GlaxoSmithKline 1473.05 1.38 24954.36 51.78 13.71 5.11 7.82 93 3,224 0.00
          Sun Pharma 609.70 1.37 146287.45 57.09 2.98 8.31 56.78 4,186 32,837 0.17
          Divis Labs 3443.25 -1.06 91407.47 48.87 12.50 18.83 62.72 1,376 5,394 0.00
          Dr Reddys Labs 4487.60 1.17 74627.94 34.31 4.78 12.98 45.38 1,969 17,517 0.11
          Cipla 813.00 3.04 65565.23 29.31 4.10 9.81 90.93 1,546 17,131 0.18

          About the Company

          {"success":1,"data":{"address":{"address1":"Dr. Annie Besant Road,","address2":"Worli,,","city":"Mumbai","state":"Maharashtra","pincode":"400030","telephone1":"022-24959595","telephone2":"","fax1":"022-24959494","fax2":"","email":"askus@gsk.com","web":"http:\/\/www.gsk-india.com"},"management":[{"name":"R S karnad","designation":"Chairperson"},{"name":"Sridhar Venkatesh","designation":"Managing Director"},{"name":"N Kaviratne","designation":"Director"},{"name":"R Krishnaswamy","designation":"Director"},{"name":"A N Roy","designation":"Director"}],"registrars":{"name":"Karvy Computershare Private Ltd.","address1":"Karvy Selenium Tower B","address2":"Plot no. 31-32, Gachibowli","address3":"Financial District","address4":"Nanakramguda","telephone":"040-23001153","fax":"","email":"","internet":"","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"500660","nseId":"GLAXO","series":"EQ","isinid":"INE159A01016"}}}
          • Registered Office

          • Registrars

            • Address

              Karvy Selenium Tower B,Plot no. 31-32, Gachibowli

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-23001153

            • Fax No.

            • Email

            • Internet

          • Management

            • R S karnad

              Chairperson

            • Sridhar Venkatesh

              Managing Director

            • N Kaviratne

              Director

            • R Krishnaswamy

              Director

            • A N Roy

              Director

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              500660

            • NSE:

              GLAXO

            • Series

              EQ

            • ISIN

              INE159A01016

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>